Oklahoma 2025 Regular Session

Oklahoma House Bill HR1005 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	Resolution
2		-	ENROLLED HOUSE
3		-	RESOLUTION NO. 1005 By: Sneed
	1	+
	2	+
	3	+	HR1005 HFLR Page 1
	4	+	BOLD FACE denotes Committee Amendments. 1
	5	+	2
	6	+	3
	7	+	4
	8	+	5
	9	+	6
	10	+	7
	11	+	8
	12	+	9
	13	+	10
	14	+	11
	15	+	12
	16	+	13
	17	+	14
	18	+	15
	19	+	16
	20	+	17
	21	+	18
	22	+	19
	23	+	20
	24	+	21
	25	+	22
	26	+	23
	27	+	24
	28	+
	29	+	HOUSE OF REPRESENTATIVES - FLOOR VERSION
	30	+
	31	+	STATE OF OKLAHOMA
	32	+
	33	+	1st Session of the 60th Legislature (2025)
	34	+
	35	+	HOUSE
	36	+	RESOLUTION 1005 By: Sneed
4	37
5	38
6	39
7	40
8	41
	42	+	AS INTRODUCED
9	43
10	44		A Resolution recognizing February 26, 2025, as
11	45		Hypertrophic Cardiomyopathy Awareness Day a t the
12	46		State Capitol; and expressing the importance of
13	47		Hypertrophic Cardiomyopathy Awareness Day .
14	48
15	49
16	50
17	51
18	52
19	53		WHEREAS, hypertrophic cardiomyopathy (HCM) is a chronic cardiac
20	54		disease involving thickening of the heart muscle and can potentially
21	55		lead to debilitating symptoms and serious complications including
22	56		heart failure, atrial fibrillation, stroke, and in rare cases sudden
23	57		cardiac death; and
24		-
25	58		WHEREAS, HCM is the most common inheritable heart disease and
26	59		can affect anyone regardless of age, gender, or ethnic ity with a
27	60		reported prevalence ranging from 1 in 200 to 1 in 500 in the general
28	61		population; and
29		-
30	62		WHEREAS, an estimated 700,000 to 1,650,000 people in the United
31	63		States have HCM, yet 85% of them may remain undiagnosed; and
	64	+
	65	+	HR1005 HFLR Page 2
	66	+	BOLD FACE denotes Committee Amendments. 1
	67	+	2
	68	+	3
	69	+	4
	70	+	5
	71	+	6
	72	+	7
	73	+	8
	74	+	9
	75	+	10
	76	+	11
	77	+	12
	78	+	13
	79	+	14
	80	+	15
	81	+	16
	82	+	17
	83	+	18
	84	+	19
	85	+	20
	86	+	21
	87	+	22
	88	+	23
	89	+	24
32	90
33	91		WHEREAS, HCM shares symptoms with o ther common cardiovas cular
34	92		and pulmonary diseases, such as shortness of breath, chest pain,
35	93		fatigue, palpitations, and fainting, making it difficult to
36	94		distinguish HCM from these other diseases; and
37		-
38	95		WHEREAS, when untreated, all-caused mortality risk is 3 t o 4
39	96		times higher in patients with HCM than that of the general
40	97		population; and
41		-
42	98		WHEREAS, knowing one's medical history and any signs and
43	99		symptoms of HCM is an important first step in receiving an accurate
44	100		diagnosis of HCM; and
45		-
46		-	ENR. H. R. NO. 1005 Page 2
47	101		WHEREAS, a health care provide r must conduct a thorough
48	102		screening with cardiac health questions to help identify a risk of
49	103		cardiac disorders both genetic and congenital; and
50		-
51	104		WHEREAS, a health care provider may conduct several tests,
52	105		including an echocardiogram, a cardiac MRI, or geneti c testing to
53	106		confirm a family history of HCM, and must examine the heart to
54	107		diagnose HCM; and
55		-
56	108		WHEREAS, following a diagnosis of HCM, it is important for
57	109		patients to work with their health care provider to learn more about
58	110		their disease and understand diffe rent management options, including
59	111		prescription medications and surgical treatment options that may
60	112		help; and
61		-
62	113		WHEREAS, the fourth Wednesday in February is an appropriate day
63	114		to observe Hypertrophic Cardiomyopathy Awareness Day.
64	115
	116	+	HR1005 HFLR Page 3
	117	+	BOLD FACE denotes Committee Amendments. 1
	118	+	2
	119	+	3
	120	+	4
	121	+	5
	122	+	6
	123	+	7
	124	+	8
	125	+	9
	126	+	10
	127	+	11
	128	+	12
	129	+	13
	130	+	14
	131	+	15
	132	+	16
	133	+	17
	134	+	18
	135	+	19
	136	+	20
	137	+	21
	138	+	22
	139	+	23
	140	+	24
	141	+
65	142		NOW, THEREFORE, BE IT RESOLV ED BY THE HOUSE OF REPRESENTATIVES
66	143		OF THE 1ST SESSION OF THE 60TH OKLAHOMA LEGISLATURE:
67		-
68	144		THAT the fourth Wednesday, February 26, 2025, is hereby
69	145		recognized by the Oklahoma House of Representatives and the State of
70	146		Oklahoma as Hypertrophic Cardiomyopathy Awa reness Day, in order to
71	147		raise public awareness about hypertrophic cardiomyopathy .
72		-
73	148		THAT the Oklahoma House of Representatives acknowledges the
74	149		critical importance of hypertrophic cardiomyopathy awareness to
75	150		improve cardiovascular health in the State of Okla homa.
76		-
77	151		THAT the Oklahoma House of Representatives supports raising
78	152		awareness of the consequences of undiagnosed and untreated
79	153		hypertrophic cardiomyopathy and the need to seek appropriate care
80	154		for hypertrophic cardiomyopathy as a serious public health issue .
81		-	ENR. H. R. NO. 1005 Page 3
82		-	Adopted by the House of Representatives the 26th day of
83		-	February, 2025.
84	155
85		-
86		-
87		-
88		-	Presiding Officer of the Hous e of
89		-	Representatives
90		-
91		-
92		-	OFFICE OF THE SECRETARY OF STATE
93		-	Received by the Office of the Secretary of State this __________
94		-	day of __________________, 20 _______, at _______ o'clock _______ M.
95		-	By: _________________________________
96		-
97		-
	156	+	DIRECT TO CALENDAR.